{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:51:43Z","timestamp":1759042303166,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005753","name":"Kungliga Fysiografiska S\u00e4llskapet i Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Dementia Association"},{"name":"Swedish Alzheimer foundation"},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Microglial cells are affected in Alzheimer\u2019s disease (AD) and interact with amyloid-beta (A\u03b2) plaques. Apart from memory loss, depression is common in patients with AD. Electroconvulsive therapy (ECT) is an anti-depressive treatment that may stimulate microglia, induce neuroinflammation and alter the levels of soluble A\u03b2, but the effects of ECT on microglia and A\u03b2 aggregation in AD are not known. We investigated the short- and long-term effects of ECT on neuroinflammation and A\u03b2 accumulation. 5xFAD mice received either electroconvulsive stimulation (ECS n\u2009=\u200926) or sham treatment (n\u2009=\u200925) for 3\u00a0weeks. Microglia and A\u03b2 were analyzed in samples collected 24\u00a0h, 5\u00a0weeks, or 9\u00a0weeks after the last treatment. A\u03b2 plaques and microglia were quantified using immunohistochemistry. The concentration of soluble A\u03b2 and cytokines was quantified using ELISA and levels of A\u03b2 aggregates were measured with Western Blot. Microglial phagocytosis of A\u03b2 in the hippocampus was evaluated by flow cytometry in Methoxy-X04 injected mice 24\u00a0h following the last ECS treatment. Y-maze and Elevated plus maze were performed to study behavior after 5\u00a0weeks. We could not detect any significant short- or long-term effects of ECS on A\u03b2 pathology or neuroinflammation, but ECS reduced abnormal behavior in the Elevated Plus maze.<\/jats:p>","DOI":"10.1038\/s41598-021-83998-0","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T11:07:32Z","timestamp":1614596852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effect of electroconvulsive therapy on neuroinflammation, behavior and amyloid plaques in the 5xFAD mouse model of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Martina","family":"Svensson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustaf","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bachiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ekemohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joakim","family":"Ekstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Deierborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"83998_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro, V. & Edison, P. Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions. Alzheimers Dement 12, 719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010 (2016).","journal-title":"Alzheimers Dement"},{"key":"83998_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12974-017-0972-9","volume":"14","author":"W Fu","year":"2017","unstructured":"Fu, W. et al. Role of microglial amylin receptors in mediating beta amyloid (Abeta)-induced inflammation. J. Neuroinflammation 14, 199. https:\/\/doi.org\/10.1186\/s12974-017-0972-9 (2017).","journal-title":"J. Neuroinflammation"},{"key":"83998_CR3","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1523\/JNEUROSCI.6546-10.2011","volume":"31","author":"D Terwel","year":"2011","unstructured":"Terwel, D. et al. Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial Abeta phagocytosis. J. Neurosci. 31, 7049\u20137059. https:\/\/doi.org\/10.1523\/JNEUROSCI.6546-10.2011 (2011).","journal-title":"J. Neurosci."},{"key":"83998_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jns.2016.08.053","volume":"369","author":"R Tokuchi","year":"2016","unstructured":"Tokuchi, R. et al. Differences between the behavioral and psychological symptoms of Alzheimer\u2019s disease and Parkinson\u2019s disease. J. Neurol. Sci. 369, 278\u2013282. https:\/\/doi.org\/10.1016\/j.jns.2016.08.053 (2016).","journal-title":"J. Neurol. Sci."},{"key":"83998_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00019052-200208000-00007","volume":"15","author":"F Assal","year":"2002","unstructured":"Assal, F. & Cummings, J. L. Neuropsychiatric symptoms in the dementias. Curr. Opin. Neurol. 15, 445\u2013450. https:\/\/doi.org\/10.1097\/00019052-200208000-00007 (2002).","journal-title":"Curr. Opin. Neurol."},{"key":"83998_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/01.ede.0000152116.32580.24","volume":"16","author":"K Andersen","year":"2005","unstructured":"Andersen, K., Lolk, A., Kragh-Sorensen, P., Petersen, N. E. & Green, A. Depression and the risk of Alzheimer disease. Epidemiology 16, 233\u2013238. https:\/\/doi.org\/10.1097\/01.ede.0000152116.32580.24 (2005).","journal-title":"Epidemiology"},{"key":"83998_CR7","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1212\/wnl.53.9.1998","volume":"53","author":"AK Berger","year":"1999","unstructured":"Berger, A. K., Fratiglioni, L., Forsell, Y., Winblad, B. & Backman, L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 53, 1998\u20132002. https:\/\/doi.org\/10.1212\/wnl.53.9.1998 (1999).","journal-title":"Neurology"},{"key":"83998_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/gps.4709","volume":"33","author":"SL Burke","year":"2018","unstructured":"Burke, S. L., Maramaldi, P., Cadet, T. & Kukull, W. Decreasing hazards of Alzheimer\u2019s disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int. J. Geriatr. Psychiatry 33, 200\u2013211. https:\/\/doi.org\/10.1002\/gps.4709 (2018).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"83998_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00124509-200403000-00004","volume":"20","author":"D Pagnin","year":"2004","unstructured":"Pagnin, D., de Queiroz, V., Pini, S. & Cassano, G. B. Efficacy of ECT in depression: a meta-analytic review. J. ECT 20, 13\u201320. https:\/\/doi.org\/10.1097\/00124509-200403000-00004 (2004).","journal-title":"J. ECT"},{"key":"83998_CR10","first-page":"1447","volume":"169","author":"TG Bolwig","year":"2007","unstructured":"Bolwig, T. G. Electroconvulsive therapy in treatment of depression. Ugeskr Laeger 169, 1447\u20131450 (2007).","journal-title":"Ugeskr Laeger"},{"key":"83998_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/s0006-3223(00)00228-6","volume":"47","author":"TM Madsen","year":"2000","unstructured":"Madsen, T. M. et al. Increased neurogenesis in a model of electroconvulsive therapy. Biol. Psychiatry 47, 1043\u20131049. https:\/\/doi.org\/10.1016\/s0006-3223(00)00228-6 (2000).","journal-title":"Biol. Psychiatry"},{"key":"83998_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.pnpbp.2009.06.007","volume":"33","author":"L Jansson","year":"2009","unstructured":"Jansson, L., Wennstrom, M., Johanson, A. & Tingstrom, A. Glial cell activation in response to electroconvulsive seizures. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 1119\u20131128. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.06.007 (2009).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"83998_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.biopsych.2005.08.032","volume":"59","author":"M Wennstrom","year":"2006","unstructured":"Wennstrom, M., Hellsten, J., Ekstrand, J., Lindgren, H. & Tingstrom, A. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol. Psychiatry 59, 178\u2013186. https:\/\/doi.org\/10.1016\/j.biopsych.2005.08.032 (2006).","journal-title":"Biol. Psychiatry"},{"key":"83998_CR14","doi-asserted-by":"publisher","first-page":"e0184603","DOI":"10.1371\/journal.pone.0184603","volume":"12","author":"EM van Buel","year":"2017","unstructured":"van Buel, E. M. et al. Mouse repeated electroconvulsive seizure (ECS) does not reverse social stress effects but does induce behavioral and hippocampal changes relevant to electroconvulsive therapy (ECT) side-effects in the treatment of depression. PLoS ONE 12, e0184603. https:\/\/doi.org\/10.1371\/journal.pone.0184603 (2017).","journal-title":"PLoS ONE"},{"key":"83998_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/YCT.0b013e31824d1f82","volume":"28","author":"L Jansson","year":"2012","unstructured":"Jansson, L., Orre, K. & Tingstrom, A. Repeated electroconvulsive seizures increase the number of vessel-associated macrophages in rat hippocampus. J. ECT 28, 174\u2013179. https:\/\/doi.org\/10.1097\/YCT.0b013e31824d1f82 (2012).","journal-title":"J. ECT"},{"key":"83998_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.expneurol.2008.04.028","volume":"212","author":"S Jinno","year":"2008","unstructured":"Jinno, S. & Kosaka, T. Reduction of Iba1-expressing microglial process density in the hippocampus following electroconvulsive shock. Exp. Neurol. 212, 440\u2013447. https:\/\/doi.org\/10.1016\/j.expneurol.2008.04.028 (2008).","journal-title":"Exp. Neurol."},{"key":"83998_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12974-015-0454-x","volume":"12","author":"EM van Buel","year":"2015","unstructured":"van Buel, E. M. et al. Electroconvulsive seizures (ECS) do not prevent LPS-induced behavioral alterations and microglial activation. J. Neuroinflammation 12, 232. https:\/\/doi.org\/10.1186\/s12974-015-0454-x (2015).","journal-title":"J. Neuroinflammation"},{"key":"83998_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/YCT.0b013e31815ef24a","volume":"24","author":"A Ingram","year":"2008","unstructured":"Ingram, A., Saling, M. M. & Schweitzer, I. Cognitive side effects of brief pulse electroconvulsive therapy: a review. J. ECT 24, 3\u20139. https:\/\/doi.org\/10.1097\/YCT.0b013e31815ef24a (2008).","journal-title":"J. ECT"},{"key":"83998_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/acps.12150","volume":"129","author":"P Nordanskog","year":"2014","unstructured":"Nordanskog, P., Larsson, M. R., Larsson, E. M. & Johanson, A. Hippocampal volume in relation to clinical and cognitive outcome after electroconvulsive therapy in depression. Acta Psychiatr. Scand. 129, 303\u2013311. https:\/\/doi.org\/10.1111\/acps.12150 (2014).","journal-title":"Acta Psychiatr. Scand."},{"key":"83998_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/YCT.0b013e318158792f","volume":"24","author":"M O'Connor","year":"2008","unstructured":"O\u2019Connor, M. et al. A dissociation between anterograde and retrograde amnesia after treatment with electroconvulsive therapy: a naturalistic investigation. J. ECT 24, 146\u2013151. https:\/\/doi.org\/10.1097\/YCT.0b013e318158792f (2008).","journal-title":"J. ECT"},{"key":"83998_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.yct.0000235926.37494.f7","volume":"22","author":"KH Kho","year":"2006","unstructured":"Kho, K. H., VanVreeswijk, M. F. & Murre, J. M. A retrospective controlled study into memory complaints reported by depressed patients after treatment with electroconvulsive therapy and pharmacotherapy or pharmacotherapy only. J. ECT 22, 199\u2013205. https:\/\/doi.org\/10.1097\/01.yct.0000235926.37494.f7 (2006).","journal-title":"J. ECT"},{"key":"83998_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1037\/0033-295x.99.2.195","volume":"99","author":"LR Squire","year":"1992","unstructured":"Squire, L. R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99, 195\u2013231. https:\/\/doi.org\/10.1037\/0033-295x.99.2.195 (1992).","journal-title":"Psychol. Rev."},{"key":"83998_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1192\/bjp.2017.11","volume":"212","author":"A Takamiya","year":"2018","unstructured":"Takamiya, A. et al. Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis. Br. J. Psychiatry 212, 19\u201326. https:\/\/doi.org\/10.1192\/bjp.2017.11 (2018).","journal-title":"Br. J. Psychiatry"},{"key":"83998_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bpsc.2017.01.011","volume":"2","author":"ST Wilkinson","year":"2017","unstructured":"Wilkinson, S. T., Sanacora, G. & Bloch, M. H. Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2, 327\u2013335. https:\/\/doi.org\/10.1016\/j.bpsc.2017.01.011 (2017).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"83998_CR25","doi-asserted-by":"publisher","first-page":"e1023","DOI":"10.1038\/tp.2016.267","volume":"7","author":"M Cano","year":"2017","unstructured":"Cano, M. et al. Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study. Transl. Psychiatry 7, e1023. https:\/\/doi.org\/10.1038\/tp.2016.267 (2017).","journal-title":"Transl. Psychiatry"},{"key":"83998_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1017\/neu.2016.22","volume":"29","author":"M Svensson","year":"2017","unstructured":"Svensson, M., Hallin, T., Broms, J., Ekstrand, J. & Tingstrom, A. Spatial memory impairment in Morris water maze after electroconvulsive seizures. Acta Neuropsychiatr. 29, 17\u201326. https:\/\/doi.org\/10.1017\/neu.2016.22 (2017).","journal-title":"Acta Neuropsychiatr."},{"key":"83998_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/hipo.22573","volume":"26","author":"M Svensson","year":"2016","unstructured":"Svensson, M. et al. Effect of electroconvulsive seizures on cognitive flexibility. Hippocampus 26, 899\u2013910. https:\/\/doi.org\/10.1002\/hipo.22573 (2016).","journal-title":"Hippocampus"},{"key":"83998_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.biopsych.2005.05.023","volume":"58","author":"J Hellsten","year":"2005","unstructured":"Hellsten, J. et al. Electroconvulsive seizures induce angiogenesis in adult rat hippocampus. Biol. Psychiatry 58, 871\u2013878. https:\/\/doi.org\/10.1016\/j.biopsych.2005.05.023 (2005).","journal-title":"Biol. Psychiatry"},{"key":"83998_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fgene.2014.00088","volume":"5","author":"SJ Webster","year":"2014","unstructured":"Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A. & Van Eldik, L. J. Using mice to model Alzheimer\u2019s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front. Genet. 5, 88. https:\/\/doi.org\/10.3389\/fgene.2014.00088 (2014).","journal-title":"Front. Genet."},{"key":"83998_CR30","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140. https:\/\/doi.org\/10.1523\/JNEUROSCI.1202-06.2006 (2006).","journal-title":"J. Neurosci."},{"key":"83998_CR31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/hipo.22267","volume":"24","author":"SD Girard","year":"2014","unstructured":"Girard, S. D. et al. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer\u2019s disease. Hippocampus 24, 762\u2013772. https:\/\/doi.org\/10.1002\/hipo.22267 (2014).","journal-title":"Hippocampus"},{"key":"83998_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1326-9-33","volume":"9","author":"V Landel","year":"2014","unstructured":"Landel, V. et al. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer\u2019s disease. Mol. Neurodegener. 9, 33. https:\/\/doi.org\/10.1186\/1750-1326-9-33 (2014).","journal-title":"Mol. Neurodegener."},{"key":"83998_CR33","doi-asserted-by":"publisher","first-page":"24939","DOI":"10.1038\/srep24939","volume":"6","author":"N Aytan","year":"2016","unstructured":"Aytan, N. et al. Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer\u2019s disease. Sci. Rep. 6, 24939. https:\/\/doi.org\/10.1038\/srep24939 (2016).","journal-title":"Sci. Rep."},{"key":"83998_CR34","doi-asserted-by":"publisher","first-page":"723915","DOI":"10.1155\/2014\/723915","volume":"2014","author":"P Rotheneichner","year":"2014","unstructured":"Rotheneichner, P. et al. Hippocampal neurogenesis and antidepressive therapy: shocking relations. Neural Plast. 2014, 723915. https:\/\/doi.org\/10.1155\/2014\/723915 (2014).","journal-title":"Neural Plast."},{"key":"83998_CR35","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.euroneuro.2016.11.004","volume":"26","author":"L Kranaster","year":"2016","unstructured":"Kranaster, L. et al. Electroconvulsive therapy selectively enhances amyloid beta 1\u201342 in the cerebrospinal fluid of patients with major depression: a prospective pilot study. Eur. Neuropsychopharmacol. 26, 1877\u20131884. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.11.004 (2016).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"83998_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-6606-4-3","volume":"4","author":"YW Zhang","year":"2011","unstructured":"Zhang, Y. W., Thompson, R., Zhang, H. & Xu, H. APP processing in Alzheimer\u2019s disease. Mol. Brain 4, 3. https:\/\/doi.org\/10.1186\/1756-6606-4-3 (2011).","journal-title":"Mol. Brain"},{"key":"83998_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0004867414557161","volume":"49","author":"KD Harrington","year":"2015","unstructured":"Harrington, K. D., Lim, Y. Y., Gould, E. & Maruff, P. Amyloid-beta and depression in healthy older adults: a systematic review. Aust. N. Z. J. Psychiatry 49, 36\u201346. https:\/\/doi.org\/10.1177\/0004867414557161 (2015).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"83998_CR38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ana.23908","volume":"74","author":"SM Landau","year":"2013","unstructured":"Landau, S. M. et al. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of beta-amyloid. Ann. Neurol. 74, 826\u2013836. https:\/\/doi.org\/10.1002\/ana.23908 (2013).","journal-title":"Ann. Neurol."},{"key":"83998_CR39","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/01.wnl.0000046581.81650.d0","volume":"60","author":"D Strozyk","year":"2003","unstructured":"Strozyk, D., Blennow, K., White, L. R. & Launer, L. J. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60, 652\u2013656. https:\/\/doi.org\/10.1212\/01.wnl.0000046581.81650.d0 (2003).","journal-title":"Neurology"},{"key":"83998_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neulet.2015.05.022","volume":"599","author":"X Zhu","year":"2015","unstructured":"Zhu, X. et al. Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid-beta peptide in depressive-like rats. Neurosci. Lett. 599, 32\u201337. https:\/\/doi.org\/10.1016\/j.neulet.2015.05.022 (2015).","journal-title":"Neurosci. Lett."},{"key":"83998_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.brainres.2014.07.046","volume":"1595","author":"X Zhu","year":"2015","unstructured":"Zhu, X. et al. Propofol inhibits inflammatory cytokine-mediated glutamate uptake dysfunction to alleviate learning\/memory impairment in depressed rats undergoing electroconvulsive shock. Brain Res. 1595, 101\u2013109. https:\/\/doi.org\/10.1016\/j.brainres.2014.07.046 (2015).","journal-title":"Brain Res."},{"key":"83998_CR42","doi-asserted-by":"publisher","first-page":"e12974","DOI":"10.1371\/journal.pone.0012974","volume":"5","author":"L Devi","year":"2010","unstructured":"Devi, L. & Ohno, M. Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLoS ONE 5, e12974. https:\/\/doi.org\/10.1371\/journal.pone.0012974 (2010).","journal-title":"PLoS ONE"},{"key":"83998_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","volume":"135","author":"F Schneider","year":"2014","unstructured":"Schneider, F., Baldauf, K., Wetzel, W. & Reymann, K. G. Behavioral and EEG changes in male 5xFAD mice. Physiol. Behav. 135, 25\u201333. https:\/\/doi.org\/10.1016\/j.physbeh.2014.05.041 (2014).","journal-title":"Physiol. Behav."},{"issue":"196","key":"83998_CR44","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A. & Wirths, O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol. Aging 33(196), e129-140. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.05.027 (2012).","journal-title":"Neurobiol. Aging"},{"key":"83998_CR45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JAD-130071","volume":"36","author":"OM Peters","year":"2013","unstructured":"Peters, O. M. et al. Chronic administration of Dimebon does not ameliorate amyloid-beta pathology in 5xFAD transgenic mice. J. Alzheimers Dis. 36, 589\u2013596. https:\/\/doi.org\/10.3233\/JAD-130071 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"83998_CR46","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41598-020-58309-8","volume":"10","author":"M Svensson","year":"2020","unstructured":"Svensson, M., Andersson, E., Manouchehrian, O., Yang, Y. & Deierborg, T. Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer\u2019s disease. Sci. Rep. 10, 1346. https:\/\/doi.org\/10.1038\/s41598-020-58309-8 (2020).","journal-title":"Sci. Rep."},{"key":"83998_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1369\/0022155416686934","volume":"65","author":"LI Estrada","year":"2017","unstructured":"Estrada, L. I. et al. Evaluation of long-term cryostorage of brain tissue sections for quantitative histochemistry. J. Histochem. Cytochem. 65, 153\u2013171. https:\/\/doi.org\/10.1369\/0022155416686934 (2017).","journal-title":"J. Histochem. Cytochem."},{"key":"83998_CR48","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41598-018-19699-y","volume":"8","author":"A Boza-Serrano","year":"2018","unstructured":"Boza-Serrano, A., Yang, Y., Paulus, A. & Deierborg, T. Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer\u2019s disease mouse model 5xFAD. Sci. Rep. 8, 1550. https:\/\/doi.org\/10.1038\/s41598-018-19699-y (2018).","journal-title":"Sci. Rep."},{"key":"83998_CR49","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1021\/cn400133s","volume":"4","author":"S George","year":"2013","unstructured":"George, S., Petit, G. H., Gouras, G. K., Brundin, P. & Olsson, R. Nonsteroidal selective androgen receptor modulators and selective estrogen receptor beta agonists moderate cognitive deficits and amyloid-beta levels in a mouse model of Alzheimer\u2019s disease. ACS Chem. Neurosci. 4, 1537\u20131548. https:\/\/doi.org\/10.1021\/cn400133s (2013).","journal-title":"ACS Chem. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83998-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83998-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83998-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:38:10Z","timestamp":1670042290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83998-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83998"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83998-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4910"}}